Catalyst Pharmaceutical Partners, Inc. to Present at 25th Annual ROTH Conference

Published: Mar 07, 2013

CORAL GABLES, Fla., March 7, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that Patrick J. McEnany, Catalyst's Chief Executive Officer, and Steven Miller, Ph.D., Catalyst's Chief Scientific Officer/COO, will be presenting an overview of the company and its progress in key programs at the 25th Annual ROTH Conference, which is being held on March 17-20, 2013 at the Ritz-Carlton in Dana Point, CA.

Back to news